JOHN KERN: Open Payments
NPI 1598366155 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 113 payments from 26 companies in 2025. Trend: 2023 $1,979 · 2024 $1,850 · 2025 $2,168
Food & beverage: $2,075Education: $92
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $419 |
| ABBVIE INC. | 27 | $406 |
| AstraZeneca Pharmaceuticals LP | 9 | $244 |
| PFIZER INC. | 10 | $181 |
| Amgen Inc. | 13 | $152 |
| Lilly USA, LLC | 5 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Exact Sciences Corporation | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
Products named: VRAYLAR, Ozempic, UBRELVY, NURTEC ODT, Wegovy, FARXIGA, BREZTRI, MOUNJARO.
Industry payments across IN — which companies pay providers there.
